Financial Snapshot

Revenue
$1.688M
TTM
Gross Margin
92.71%
TTM
Net Earnings
-$3.021M
TTM
Current Assets
Q4 2022
Current Liabilities
Q4 2022
Current Ratio
42.28%
Q4 2022
Total Assets
Q4 2022
Total Liabilities
Q4 2022
Book Value
-$3.075M
Q4 2022
Cash
Q4 2022
P/E
-2.387
Jul 18, 2023 EST
Free Cash Flow

Revenues

Revenues

Revenue YoY Change

Revenues

Concept 2022 2021 2020 2019 2010 2009 2008 2007 2006 2005

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept 2022 2021 2020 2019 2010 2009 2008 2007 2006 2005

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept 2022 2021 2020 2019 2010 2009 2008 2007 2006 2005

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept 2022 2021 2020 2019 2010 2009 2008 2007 2006 2005

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept 2022 2021 2020 2019 2010 2009 2008 2007 2006 2005

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

No data

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

No data

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

No data

Assets & Liabilities

Concept 2022 2021 2020 2019 2010 2009 2008 2007 2006 2005

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

No data

Preferred Stock

No data

Treasury Stock Shares

No data

Stock Issuance & Repurchase

Ownership Data

Concept 2022 2021 2020 2019 2010 2009 2008 2007 2006 2005

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Dividends

No data

Stock Price

Market Cap: $7.21 Million

About Healthtech Solutions, Inc./UT

Healthtech Solutions, Inc. is a holding company, which engages in the provision of financial documents printing services through its subsidiaries. The company is headquartered in Tuckahoe, New York and currently employs 18 full-time employees. The company went IPO on 2012-03-15. Its portfolio of subsidiaries includes Healthtech Wound Care, Inc. (HWC), Cellsure, LLC (Cellsure), The Clia Lab, LLC (The Clia Lab), Medi-Scan Inc. (MediScan), and RevHeart Inc. (RevHeart). HWC is focused on identifying and developing a pipeline of human cell and tissue product candidates. Cellsure is engaged in the business of collecting placenta and other birth tissue, then making it available for research and development purposes as well as wound care and surgical treatments. The Clia Lab is a certified diagnostic laboratory, which is dedicated to aiding healthcare providers to screen for and monitor specific diseases. MediScan is a company developing advanced ultrasound imaging and artificial intelligence (AI) based image analysis software. Its portfolio also includes World Reach Holdings, LLC (WR Holdings) and its subsidiaries.

Industry: Surgical & Medical Instruments & Apparatus Peers: